Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-09-06

Clinical Trial Update: Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease

View source ↗

Summary

A clinical trial update examining determinants of EsophyX efficacy in gastroesophageal reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EsophyX

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Gastroesophageal Reflux Disease | Status: UNKNOWN